Morbidity and mortality in HIV - infected children admitted at Moi Teaching and Referral Hospital in Western Kenya by Nyandiko, W et al.
July 2011 East african MEdical Journal   229
East African Medical Journal Vol. 88 No. 7 July 2011
MORBIDITY AND MORTALITY IN HIV-INFECTED CHILDREN ADMITTED AT MOI TEACHING AND REFERRAL 
HOSPITAL IN WESTERN KENYA 
W. Nyandiko, MBChB, MMed, Department of Child Health and Paediatrics, Moi University School of Medicine,and 
USAID-Academic Model Providing Access to Healthcare (AMPATH), P. O. Box 4606, Eldoret, Kenya, A. W. Mwangi, 
MSc, E. Sang, BSc, USAID-Academic Model Providing Access to Healthcare (AMPATH), R. Vreeman, MD, MS, USAID-
Academic Model Providing Access to Healthcare (AMPATH), P. O. Box 4606, Eldoret and Children’s Health Services 
Research, Department of Paediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA, I. Marete, 
MBChB, MMed, E. Nabakwe, MBChB, MMed, C. Tenge, MBChB, MMed, P. Gisore, MBChB, MMed, J. Songok, MBChB, 
MMed, Department of Child Health and Paediatrics, Moi University School of Medicine and USAID-Academic Model 
Providing Access to Healthcare (AMPATH), J. Kiplagat, BSc, E. Walumbe, USAID-Academic Model Providing Access 
to Healthcare (AMPATH) and S. Ayaya, MBChB, MMed, Fderm, Department of Child Health and Paediatrics, Moi 
University School of Medicine and USAID-Academic Model Providing Access to Healthcare (AMPATH), P. O. Box 
4606 Eldoret, Kenya 
Request for reprints to: Dr. W. Nyandiko, Department of Child Health and Paediatrics, Moi University School of Medicine 
and USAID-Academic Model Providing Access to Healthcare (AMPATH), P. O. Box 4606, Eldoret, Kenya
MORBIDITY AND MORTALITY IN HIV-INFECTED CHILDREN ADMITTED 
AT MOI TEACHING AND REFERRAL HOSPITAL IN WESTERN KENYA
W. NYANDIKO, A. W. MWANGI, E. SANG, R. VREEMAN, I. MARETE, E. NABAKWE, C. TENGE, 
P. GISORE, J. SONGOK, J. KIPLAGAT, E. WALUMBE and S. AYAYA 
ABSTRACT
Background: HIV-infected children are at higher risk of opportunistic infections that 
could result in hospitalisation. The outcomes of hospitalisation are variable and 
depend on the admission diagnosis, the patients’ immune status and whether or not 
the patient is on anti-retroviral drugs. 
Objective: To describe the characteristics and causes of hospitalisation and mortality for 
HIV infected children admitted to Moi Teaching and Referral Hospital in Western Kenya.  
Design: A retrospective study of prospectively collected data. 
Setting: The paediatric wards of Moi Teaching and Referral Hospital (MTRH). A 
Kenyan National Referral Hospital. 
Subjects: HIV-infected children admitted the paediatric wards.
Interventions: Treatment with combination anti-retroviral therapy (cART), treatment 
of common opportunistic infections. 
Main outcome measures: Demographic and clinical data, including diagnosis, immune 
status, and treatment with combination anti-retroviral therapy (cART), were extracted 
from hospital admission records of HIV-infected children registered with the USAID-
Academic Model Providing Access to Healthcare (AMPATH) partnership. We conducted 
descriptive statistical analyses and used chi-square and fisher’s exact tests to assess 
for associations between categorical variables and each of the independent variables.  
Results: Between December 2006 and May 2009, 396 HIV-infected children were 
admitted to MTRH. Median age at admission was 2.0 years (range 0-15); 236 (59%) were 
male; 36 (15%) of available 236 orphan status entries were orphaned; 198 (73%) were 
in CDC categories B and C and 61 (16%) of available 386 had been on ART. Among 
108 patients with documented immunologic status, the mean CD4 cell percentage was 
16% (SD 10.8). Among the 396 children, 104 (15%) were diagnosed with pneumonia, 92 
(14%) with gastroenteritis, 36 (9%) with tuberculosis and 37 (9%) with malaria. Deaths 
occurred in 28(7%) of the patients. The median duration of hospitalisation was seven 
days (range 1- 516) for discharged patients and six days (range 0-72) for those who died. 
A significantly higher percentage of the children who were not previously enrolled 
in AMPATH died, signifying 14 (15%) mortality among this population of admitted 
patients, p = 0.0017. Of those who died, (17%) were diagnosed with pneumonia and 
22 (79%) of them were not on cART. 
Conclusion: The common diagnoses at hospitalisation included pneumonia, 
gastroenteritis, malaria and tuberculosis. Higher mortality occurred among those 
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diagnosed with pneumonia and those not previously enrolled in the HIV care 
programme. Aggressive treatment and prevention of the most prevalent diseases 
and early enrollment into HIV care are recommended for HIV-infected children. A 
follow-up study to investigate the pathological causes of death in this population is 
recommended. 
INTRODUCTION 
In Kenya, over 1.3 million people are HIV infected, 
including over 150,000 children (1). The adult 
prevalence has declined from a high of 15% in 1998 
to a current low of 7.8 % (2). There are over 1,100,000 
orphans in Kenya due to parental HIV-infection and 
death. In 2005 alone, over 140,000 people died from 
HIV infection/AIDS in the country. HIV infection 
is one of the top five causes of mortality in Kenya 
and has greatly contributed to the infant mortality 
rate rising from 73 per 1000 in 1998 to over 78 per 
1000 in 2004 (3) and the under-five mortality rate 
rising from 112 per 1000 in 1998 to 120 per 1000 in 
2004 (4). The number of paediatric HIV infection 
related hospitalisations and deaths have increased 
markedly in the last decade. Data from Moi Teaching 
and Referral Hospital (MTRH) in western Kenya, the 
second largest referral hospital in the country, show 
that HIV infection related paediatric admissions 
have been increasing over the last decade. The 
percentage of adult deaths attributable to HIV 
infection related causes during this same period 
rose from 2 to 15% (hospital annual summaries). 
 Although the spectrum of HIV-related disease 
has been reported in several African countries, few 
studies have evaluated the causes of HIV-related 
morbidity and mortality, particularly for children 
(5-8). While some studies have reported the causes 
of death in HIV infected children in Africa, the 
majority of them rely on clinical diagnoses (6, 9-16). 
In the past decade, studies investigating pathologic 
causes of death and evaluating the outcomes of 
efforts to prevent HIV infected associated preventable 
diseases have been published (7, 8, 17-21). In studies 
of HIV-infected children from West and Southern 
African countries, HIV infected children were found 
to develop pulmonary and neurological diseases, 
including pneumocystis carinii pneumonia (PCP), 
tuberculosis, interstitial pneumonitis, meningitis, 
and cytomegalovirus. However, no study has 
described the situation in the East African region. 
Better information on the causes of hospitalisation, 
morbidity, and mortality for HIV infected children 
in particular resource-limited settings is needed. 
In addition, in a system of care where appropriate 
diagnostic capabilities for HIV-infected children are 
limited by few referral facilities and other resource 
limitations, there is a need for evidence-based 
decisions and guidelines to help clinicians use 
available treatment options wisely. Accurate, up-to-
date, and regionally specific clinical and pathologic 
data are, therefore, needed to improve clinical 
management of HIV-infected children. 
 The United States Agency for International 
Development (USAID) - Academic Model Providing 
Access to Healthcare (AMPATH) Partnership in 
collaboration between Moi University, MTRH, 
partner institutions from the United States (led by 
Indiana University) and was originally established to 
provide HIV infection care within public sector clinics 
in western Kenya (22). The AMPATH partnership 
currently provides HIV infection prevention and 
treatment services at 23 clinics in western Kenya, 
all but one of which is Ministry of Health (MOH)-
affiliated. All USAID-AMPATH HIV infection clinics 
refer patients for admission to nearby sub-district 
or District Hospitals. More complex and difficult 
cases that require more advanced laboratory and 
radiological tests are referred to the MTRH in Eldoret. 
AMPATH’s largest HIV clinic, which currently cares 
for over 4,600 children, is also located on the grounds 
of MTRH, and children from this clinic and other 
distant clinics requiring specialist care are referred 
to MTRH for admission. 
The purpose of this study was to describe the 
characteristics and outcomes of hospitalisation for 
HIV-infected children admitted to the Moi Teaching 
and Referral Hospital. 
MATERIALS AND METHODS  
Study Design: The study was approved by the 
Institutional Research and Ethics Committee of 
the Moi University School of Medicine and MTRH 
and the Institutional Review Board of the Indiana 
University School of Medicine. This was a combined 
cross-sectional and retrospective cohort study 
using data from charts of admitted patients and 
prospectively collected de-identified data stored 
in the computerised medical records system of 
paediatric patients already enrolled in the USAID-
AMPATH clinics (23). 
Study Population and Setting: Records from admission 
charts and the computerised medical records of 
HIV-infected children admitted to MTRH between 
December 2006 and May 2009 were reviewed for 
inclusion into this study. 
 During the study period, the USAID-AMPATH 
clinic system operated between 12 and 23 clinics in 
western Kenya. There has been a steady rise in the 
number of clinics operated by the programme, in 2004; 
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there were only four clinics, rising to 18 clinics in 2008 
and 23 in 2010. The largest urban clinic is located at 
the MTRH in Eldoret. It serves the whole of western 
Kenya with a population of over 15 million people. 
The monthly admissions to the paediatric wards range 
between 100 to 160 children. Due to the comprehensive 
and widespread nature of USAID-AMPATH system 
of clinics, most HIV infected patients in the North 
Rift and western Kenya regions get care within the 
AMPATH clinics. HIV infection clinics for adults, 
children, or combined populations were conducted 
two to five days per week at all sites (24, 25). Those 
requiring admission were sent to the nearby district 
hospitals or MTRH. As of May 2009, AMPATH had 
56(962) active patients, including 44,780 adults and 
12,182 children. Of these patients, 30,854 were on 
combination anti-retroviral therapy (cART). 
Clinical Procedures: Throughout the period of the 
study, clinicians followed detailed, locally developed 
protocols consistent with World Health Organisation 
guidelines. Children whose HIV infection status were 
not already known were tested for HIV infection 
at the sick child clinic at admission or in the wards 
after admission. This was the normal hospital policy 
during the period of the study. HIV infection was 
documented by DNA-PCR (Amplicor, Roche, Basel, 
Switzerland) for children greater than 18 months 
and by two parallel HIV rapid ELISA tests using 
Determine and Unigold kits for children less than 18 
months. cART was initiated for any child more than 
six years of age with a CD4 cell percentage of greater 
than 15%, for any child lesser than six years of age 
with a CD4 count greater than 200 cells/mm3, and for 
all children with WHO clinical stages 3 or 4 or CDC 
stage C disease. The standard initial cART regimens 
used were zidovudine/lamivudine/nevirapine for 
those weighing greater than 10kg or stavudine/
lamivudine/nevirapine for those weighing less than 
10kg. All patients were started on cotrimoxazole 
preventive therapy if below the age of six years. Those 
above six years of age with a CD4 cell percentage of less 
than 25% and those with WHO stages 3 or 4 were also 
put on cotrimoxazole. Children started on cART were 
seen two weeks after initiation of therapy, and then 
every month thereafter. During these visits, patients 
undergo clinical assessments, including assessment 
of family and social characteristics, nutritional status, 
the degree of immuno-suppression, current or chronic 
infections, dietary intake, drug treatment history 
and adherence history. An orphan was defined as a 
child who had lost either both or one of his or her 
parents. Laboratory investigations included routine 
assessment of CD4 percentage every six months and 
investigations to evaluate haemoglobin level, liver 
and kidney functions every three months. Tests to 
evaluate for toxicities were performed as necessary. 
Our outcomes of interest were death or discharge. 
The independent variables included age, gender, 
orphan status, ever on ARV’s, previously enrolled 
in AMPATH, CDC stage, recent CD4 cell count and 
percentage and admission diagnosis. Patients were 
admitted if they had clinical indications as diagnosed 
by the clinicians in the various sites. 
Data Collection and Management: For patients already 
enrolled in AMPATH, clinicians normally completed 
standard initial and return encounter forms at all 
USAID-AMPATH clinic visits for the children. 
The AMPATH encounter forms included standard 
demographic, birth, past and present medical 
history, physical examination, laboratory data and 
medications provided including anti-retroviral drugs 
and opportunistic infection prophylaxis. Dedicated 
data entry clerks entered this information into the 
ambulatory USAID-AMPATH Medical Record 
System with data entry validated by random review 
of 10% of the data entered. The medical records 
system was MS-Access-based (Microsoft Corporation, 
Redmond, WA) until 2006, and currently uses MySQL 
based database. 
 Hospital admission notes from MTRH were 
entered into admission encounter forms by dedicated 
research assistants who traced all HIV infected 
children admitted to MTRH. The independent 
variables included demographic history (age, gender, 
clinic site, orphan status), AMPATH enrollment, 
CD4 cell percentage closest to admission, admission 
and discharge or death diagnosis and use of cART. 
The dependent variables included the outcome of 
discharge or death and duration of hospital stay. 
Information on children’s hospital admissions 
from the distant clinic sites was collected from the 
AMRS. 
Statistical methods: Descriptive statistics, such as mean, 
standard deviation, median and range, were used for 
the continuous variables, while frequency listings 
were used for categorical variables. The chi-square 
test was used to assess for associations between a 
categorical variable and each of the independent 
variables. Where the cell counts were below ten, the 
Fishers’ exact test was used in two by two tables. The 
Kruskal-Wallis test was used to compare the medians 
for continuous variables. All statistical analyses 
were performed using SAS Institute version 9.1. A 
p-value of less than 0.05 was considered significant 
in all analyses. 
RESULTS 
Data were available for 396 HIV-infected patients of 
11,972 children who were admitted in MTRH from the 
December 2006 to May 2009. This formed 3.3% of all 
admissions to the paediatric wards during the period. 
The median age at admission was two years (range: 
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0-15 years), with the majority having been previously 
enrolled in AMPATH (Table1). More than half of the 
children were boys 236 (59%) and 36 (15%) of 236 with 
recorded orphan status were orphaned at admission. 
For the 108 with documented immunologic status, the 
mean CD4 cell percentage closest to admission was 
16% (Table 1). In the whole cohort, the majority of the 
children were in CDC category B 173 (43%) and C 81 
(30%). Sixty one (16%) of the children were already 
on cART from AMPATH. Pneumonia was the most 
common final diagnosis for HIV-infected children 
admitted in the hospital. One hundred and four (15%) 
of the children were diagnosed with pneumonia, 92 
(14%) with gastroenteritis, 36 (9%) with tuberculosis 
and 37 (9%) with malaria (Tables 1 and 2). 
 Among those already enrolled in AMPATH prior 
to admission, the median age was two (range 0-15), 33 
(18%) were orphans among the 188 with documented 
orphan status and 58 (20%) of 297 were recorded ever 
having been on ARV’s. They had a median CD4 cell 
percentage of 15 (range 0-45), with 166 (76%) being in 
CDC categories B and C (Table 2). Those not previously 
enrolled in AMPA TH tended to be younger, with a 
median age of 1.7 years (range 0-14) (Table 2). They 
were much less often orphaned, and only three (3%) 
of them had ever been on ARV’s. Like the children 
enrolled in AMPATH, the majority of the un-enrolled 
children also had moderate and severe disease, with 
29 (67%) of them being in CDC categories B and C. 
 More than half 220 (55%) of the children were 
discharged, 28 (7%) died with 152 missing entries. 
The median time to death after admission was six 
days (range 0-72). The median duration to discharge 
was seven days (range 1-516). Six (21%) of those 
on ART died compared to 22 (79 %) of those who 
had not been initiated on ART. The most common 
diagnosis for those who died was pneumonia (17%), 
followed by lymphoma (10%) and meningitis (7%). 
When comparing those who died to those who 
were discharged home, those previously enrolled in 
AMPATH were significantly less likely to die 14 (4.6%) 
than those not previously enrolled 14 (15%), p-value 
0.0017. Gender, ever on ARV, orphan status, age at 
admission and recent CD4 cell percentage were not 
significantly different between the two groups (Tables 
4 and 5).
 Among the children already followed by 
AMPATH at the time of hospital admission, 14 
(4.6%) died during their hospitalisation (Table 2). A 
significantly higher percentage of the children who 
were not previously enrolled in AMPATH died, 
with 14 deaths, signifying 15% mortality among this 
population of admitted patients, p-value 0.00017 (Table 
3). The previously enrolled children who died were 
older, with a median age of 3.75 (range 0-12). The 
enrolled children who died were also more likely to 
be male (71 %), orphans (38%), and on ARV’s (36%) 
than the enrolled children who did not die. The 
enrolled children who died also had immunological 
characteristics of more severe HIV infection disease. 
They had a median CD4 cell percentage of nine (range 
1-21), and 90% were in CDC categories B and C. 
Table 1
Characteristics of HIV-infected children admitted in the pediatric wards 
at Moi Teaching and Referral Hospital  
Characteristic    Frequency
  N=396   
Age at admission (years)       
 Median (range)    2.0 (0 -15)  
 Mean (SD)    3.33 (3.86)   
Gender     
 Male    236 (59.15)
 Missing    1   
Orphan     
 Yes    36 (15.00%)   
 Missing    160   
Previously enrolled in AMPATH    305(76.63%)   
Ever on ARV     
 Yes    61 (15.64%)   
 Missing    10   
Recent CD4    N=106   
 Mean (SD)    648.16(703.89)
 Median (range)    420 (0,3696)
Recent CD4%    N=108   
 Mean (SD)    16.35(10.82)   
 Median(range)    15(0.45)   
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Admission outcome     
 Discharged    220(55.14%
 Died    28(7.02%
 Unknown    152(37.84%)
CDC class at admission     
 N    15(5.54%
 A    58(21.40%
 B    117 (43.17)
 C    81(29.89%)  
 Missing    129  
Time to death since admission (days)  N=26    
 Median (range)  6(0,72)  
 Mean (SD)  16.91(21.18)    
Time to discharge since admission (days)  N=21 0    
 Median (range)  7.00 (1516)    
 Mean (SD)  23.36(58.55)   
Diagnosis    N=400    
 Pneumonia    104   
 Malaria    37     
 Tuberculosis    36     
 Gastroenteritis/diarrhea    67     
 Meningitis    12     
 Dehydration    25   
 Immuno-suppression    37    
 Malnutrition    8  
 Lymphoma    5    
 Karposis sarcoma    4    
 Anemia    9    
 Brochiolitis    2    
Table 2
Characteristics of children by previous enrolled in AMPATH  
Characteristic                        Frequency  
  Previously enrolled  Not previously  
  (N=305) enrolled (N=93)  
Age at admission (years)    N=302    N=92  
 Median (range)    2(0-15)    1.71 (0- 14)    
 Mean (SD)    3.36(3.86)    3.16(3.79)   
Gender          
   Male    171 (56.25%)    63 (67.74%)    
   Missing    1      
Orphan          
   Yes    33 (17.55%)    2(3.92%)    
   No    155 (82.45%)    49 (96.08%)    
   Missing    117    42    
Ever on ARV        
 Yes    58 (19.53%)    3 (3.26)    
 No    239 (80.47%)    89(96.74%)    
 Missing    8    1    
Recent CD4    N=105      
 Mean (SD)    645 (706.51)    -    
 Median (range)    416 (0,3696)      
Recent CD4%    N=107      
 Mean(SD)    16.31 (10.86)    -    
 Median (range)    15 (0,45)      
Admission outcome        
 Discharged    145 (47.54%)    74 (80.43%)    
 Died    14 (4.59%)    14 (15.22%)    
      146 (47.87%)    4 (4.35%)    
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CDC class at admission  
 N    11 (5.02%)    13 (25.49%)    
 A    42 (19.18%)    4 (7.84%)    
 B    98 (44.75%)    16 (31.37%)    
 C    68 (31.05%)    13 (35.29%)    
 Missing    86    42    
Diagnosis    N=305    N=93    
 Pneumonia    77    27    
 Malaria    21    16    
 Tuberculosis    25    11    
 Gastroenteritis    31    26    
 Meningitis    7    5    
 Dehydration    15    9    
 Immuno-suppression    26    10    
 Malnutrition    5    3    
 Lymphoma    2    3    
 Kaposis Sarcoma    4    0    
 Diarrhea    8    1    
 Anemia    9    0    
Table 3
Characteristics of children previously enrolled in AMPATH who died in the wards in MTRH  
Characteristic          Frequency    
  N=14    
Age at admission (years)              N=14    
 Median (range)              3.75 (0 -12)    
 Mean (SD)              4.19 (3.58)    
Gender                  
   Male              10 (71.43%)    
   Female              4 (28.57%)    
Orphan                  
   Yes              3 (27.27%)    
   No              8 (72.73%)    
Ever on ARV                
 Yes              5 (35.71%)    
 No              9 (64.29%)    
Recent CD4 count N=5    
  Mean (SD) 403.80(399.04)    
  Median (range) 360(20.00,889.00) 
Recent CD4%              N=5    
 Mean(SD)              9.8(9.12)    
 Median(range)              9.00(1.00,21.00)    
CDC class at admission                
 A              1(9.09%)    
 B              2(18.18%)    
 C              8(72.73%)    
 Missing              3    
Diagnosis at admission (first admission)          N=14    
 Pneumonia             2    
 Malaria              0    
 Tuberculosis              1    
 Gastroenteritis              0    
 Meningitis              0    
 Malnutrition              0    
 Lymphoma              1   
 Kaposis Sarcoma              1    
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Table 4
Association between death and gender, ever on ART, orphan status, enrolled at AMPATH 
Variable   Confirmed death    Discharged/    Fisher    
  N=28 Unknown N=371    exact p-value 
Gender            
   Male    20 (71.43%)    216 (58.22%)    0.2314   
   Female    8 (43.75%)    155 (41.78%)      
Ever on ARV          
   Yes    6 (21.43%)   55 (15.19%)    0.4155    
   No    22 (78.57%)    307 (84.81 %)      
Orphan            
 Yes    3 (23.08%)    33 (14.54%)    0.4202    
 No    10 (76.92%)    194 (85.46%)      
Previously enrolled at AMPATH          
 Yes    14 (50%)    291 (78.65%)    0.0017    
 No    14(50%)    79 (21.35%)     
Table 5
Median age and CD4% among those confirmed dead and those discharged or vital status unknown  
Variable    Confirmed death  Discharged/    Kruskal    
      N=28 Unknown N=371    wallis p-value   
Age at admission (years)    N=28    N=368      
 Mean (SD)    3.90 (4.01)    3.29 (3.84)    0.3915    
 Median range    2.91 (0.13)    2 (0.15)      
Recent CD4%    N=5    N=103      
 Mean (SD)    9.80 (9.12)    16.67 (10.82)    0.1782    
 Median (range)    9 (1.21)    15 (0.45) 
DISCUSSION  
In this paper, we describe the findings and outcomes 
of HIV-infected children admitted to the main 
referral hospital in western Kenya. We describe the 
general demographic characteristics, the clinical 
characteristics and then the outcomes. The main 
findings were the differences between HIV-infected 
children who had previously been enrolled in the 
AMPATH programme and those who had not been 
enrolled before admission. We found that those 
previously admitted to the AMPATH programme 
were less likely to die if admitted to the hospital. 
They also tended to have higher CDC classification 
and CD4 cell percentage, though these were not 
statistically significant. 
 The higher mortality among HIV-infected 
patients who present to the hospital without being 
previously enrolled to the AMPATH programme has 
also been described among the adult population of 
patients admitted to the same hospital (26). These 
findings are also consistent with other studies from 
Nairobi, which showed increased mortality among 
those presenting with low CD4 cell counts (27). It is 
plausible that the lower mortality among children that 
are enrolled earlier into care system from the fact that 
they are more likely to be evaluated for opportunistic 
infections and to be initiated on prophylaxis against 
the common causes of HIV infection, including PCP 
or TB. All HIV-infected children enrolled in AMPATH 
are initiated on cotrimoxazole for life. They should, 
therefore, be less sick and have better outcomes upon 
admission to the wards. Not only may the children 
not enrolled in this care programme be missing 
key prophylaxis regimens and routine medical 
evaluations, but they also may be a population that 
has shied away from care due to stigma. They may 
also be orphaned and lack other protective factors, 
such as supportive families and social environments, 
and this may not augur well for optimal outcomes 
to hospitalisation (28). 
 The majority of children who died after 
admission were in CDC categories B and C, 
suggesting they had more severe disease at admission 
than those who were ultimately discharged home 
alive. Similar findings have been described among 
HIV-infected children in South Africa (11) and in 
adults admitted in the same hospital (26). It is also 
important to note that the immunologic status of all 
those admitted was severely depleted, indicating the 
vulnerability to common infections and opportunistic 
infections. And, although it was not statistically 
significant, those who died tended to have lower 
CD4 cell percentage compared to those who were 
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discharged. This has been described in a paediatric 
cohort in Nairobi (27) and in the adult population 
of admitted HIV infected patients in AMPATH 
(26). These findings all point to the importance of 
careful monitoring and aggressive medical care 
for HIV-infected children with more severe disease 
staging and impaired immunological functioning. 
 The common admission diagnoses were 
pneumonia, gastroenteritis and tuberculosis, which 
is similar to other studies of HIV-infected children in 
sub-Saharan Africa (5, 6, 10, 12, 16). Zambia and South 
Africa have shown the benefits of these preventive 
strategies (17-19). The AMPATH programme has 
since introduced INH prophylaxis to all HIV-infected 
children seen in the programme who are evaluated 
and found not to have active TB.
 Among the hospitalised children who died, 
pneumonia was the most common diagnosis, 
consistent with outcomes described for HIV-infected 
children in South Africa, Zimbabwe, Ivory Coast, 
Botswana and Uganda (6, 8, 9, 11, 12, 29). While we 
could not identify the causes of these pneumonia, 
it is known that HIV-infected children frequently 
get pneumonia caused by the common pathogens 
such as Streptococcus pneumoniae and Haemophilus 
influenza, but these pathogens tend to cause more 
severe disease and higher mortality in children with 
HIV infection (30). HIV-infected children are also 
at risk for pneumonia cause by pathogens such as 
Pneumocystis carinii, reinforcing the importance of 
cotrimoxazole prophylaxis. 
 This study does have several limitations that bear 
consideration. No details regarding the treatments 
given to the children was available for analysis; 
however, we were still able to provide a description 
of the children’s characteristics and their diagnoses. 
Moreover, these data rely on the admission and 
discharge or death diagnoses listed in the inpatient 
charts, which did not allow us to tease out the co-
morbidities. The distant AM PATH related admissions 
to the district hospitals and health centres were not 
described although some few patients were referred 
for inpatient specialised care to MTRH; the outcomes 
might therefore not have been representative of 
the whole spectrum of AMPATH care. However, 
MTRH does cover a catchment’s area of two million 
people. Because of the nature of MTRH as a referral 
hospital, these data probably allowed us to capture 
the HIV-infected children with more severe illnesses 
and, perhaps, with a higher likelihood of death. The 
fact that the analysis is for patients admitted in a 
national referral hospital means that it may not be as 
generalisable to outcomes in smaller health facilities. 
Nonetheless, these data provide a description of the 
HIV-infected children requiring or receiving referral 
care, and it is helpful for clinical programmes to be 
able to estimate the inpatient burden, as well as some 
of the risk factors for mortality. 
In conclusion, the most common diagnoses at 
hospitalisation included pneumonia, gastroenteritis, 
malaria and tuberculosis. Higher mortality occurred 
among those diagnosed with pneumonia and those 
not previously enrolled in the HIV care programme. 
Recommendations: Aggressive treatment and 
prevention of the most prevalent diseases and early 
enrollment into HIV care are recommended for HIV-
infected children. A follow-up study to investigate 
the pathological causes of death in this population 
is recommended. 
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